首页 | 本学科首页   官方微博 | 高级检索  
检索        


Adjuvant high dose rate brachytherapy (Ir-192) in the management of keloids which have recurred after surgical excision and external radiation.
Authors:Madhur K Garg  Paul Weiss  Anand K Sharma  Giridhar R Gorla  Wainwright Jaggernauth  Ravindra Yaparpalvi  John Delrowe  Jonathan J Beitler
Institution:Department of Radiation Oncology, Montefiore Medical Center, Bronx, NY 10467, USA.
Abstract:We describe our experience with adjuvant high dose rate brachytherapy (Ir-192) (HDRB) in patients, who failed surgery and post-operative external radiation therapy. The salvage treatment consisted of excision of the keloid and wound closure followed by HDRB (15 Gy in three fractions given on three consecutive business days beginning the day of surgery). At the time of last follow up, 88% (15/17) of the keloids were without any evidence of recurrence.
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号